(AVUV) Avantis U.S. Small Cap Value - Ratings and Ratios
U.S., Small Cap, Value, Equity, Derivatives
Dividends
| Dividend Yield | 1.59% |
| Yield on Cost 5y | 3.26% |
| Yield CAGR 5y | 22.74% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.0% |
| Value at Risk 5%th | 31.7% |
| Relative Tail Risk | -8.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.07 |
| Alpha | -10.81 |
| CAGR/Max DD | 0.50 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.494 |
| Beta | 1.017 |
| Beta Downside | 1.082 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.79% |
| Mean DD | 6.98% |
| Median DD | 5.35% |
Description: AVUV Avantis U.S. Small Cap Value October 16, 2025
The Avantis® U.S. Small-Cap Value ETF (AVUV) targets a broad cross-section of U.S. small-cap equities, allocating at least 80 % of its net assets to companies with market capitalizations generally under $5 billion. The fund may also employ derivative instruments-including futures, currency forwards, and swaps-to manage exposure, enhance liquidity, or hedge currency risk, while remaining constrained to a U.S.-focused investment universe.
As of the most recent quarterly filing (Q3 2024), AVUV’s average holding size is roughly $2.1 billion, with the top three sectors being Financials (≈ 24 % of assets), Industrials (≈ 19 %), and Consumer Discretionary (≈ 15 %). The ETF’s expense ratio stands at 0.30 %, and its annual turnover is about 45 %, indicating moderate portfolio churn. Performance has historically tracked the Russell 2000 Value Index, with a 12-month excess return of +1.8 % during a period of rising short-term rates-a key macro driver that tends to compress valuations for rate-sensitive small-cap firms.
For a deeper, data-driven look at how AVUV’s valuation metrics compare across the small-cap space, you might explore the ValueRay platform’s interactive screens.
What is the price of AVUV shares?
Over the past week, the price has changed by +2.15%, over one month by +5.90%, over three months by +5.44% and over the past year by +4.16%.
Is AVUV a buy, sell or hold?
What are the forecasts/targets for the AVUV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 118.1 | 12.3% |
AVUV Fundamental Data Overview December 12, 2025
Beta = 1.2
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 20.52b USD (20.52b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 20.52b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 20.52b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.76% (E(20.52b)/V(20.52b) * Re(9.76%) + (debt-free company))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for AVUV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle